Mitsui Chemicals, Inc. will establish a holding company in the United States to facilitate the transfer of global headquarters functions following the acquisition of Ultradent, promoting growth and efficiency in the oral care business.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4183","jir_company_name":"Mitsui Chemicals, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-07-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/4183-20260714-01.pdf","jir_short_summary":"Mitsui Chemicals, Inc. will establish a holding company in the United States to facilitate the transfer of global headquarters functions following the acquisition of Ultradent, promoting growth and efficiency in the oral care business.","jir_summary":"### Business Strategy and Purpose of Establishing the New Company\nMitsui Chemicals, Inc. will transfer the global headquarters of its oral care business to the US following the acquisition of Ultradent, aiming to optimize business operations and pursue growth investments. The newly established holding company will manage Ultradent's shares and assets, promote PMI initiatives, and maximize the synergy effects of the group. This will strengthen the Life & Healthcare Solutions business pillar and aim to become a leading company in the dental healthcare field.\n\n### Future Outlook and Impact on the Company\nThe establishment of the holding company is expected to have a minor impact on our performance, but additional information will be disclosed as progress is made. Through the acquisition and organizational restructuring, we aim to accelerate the global expansion and efficiency of the oral care business, building a foundation for long-term growth.","jir_financial_highlights":"Capital of the Holding Company: USD 900 million (scheduled) (Capital at establishment is planned to increase from USD 100)\nEstablishment Date: July 24, 2026 (scheduled) (Unknown)","jir_category":"","jir_hashtags":"#MitsuiChemicals, #IR, #JapanStocks","jir_key_figures":"Capital of the holding company: USD 900 million (scheduled)\nScheduled establishment date: July 24, 2026\nCapital increase related to acquisition: planned increase from USD 100 to USD 900 million","jir_meta_title":"\u3010Mitsui Chemicals\u3011Acquisition of Ultradent in the US and Establishment of New Company | July 2026","jir_meta_description":"Mitsui Chemicals, Inc. will establish a holding company in the US to facilitate the transfer of its global headquarters following the acquisition of Ultradent, promoting business expansion and efficiency.","jir_og_title":"\u3010Mitsui Chemicals\u3011Ultradent Acquisition and New Company Establishment | July 2026","jir_og_description":"Mitsui Chemicals will accelerate the global expansion of its oral care business by establishing a new company in the US following the acquisition of Ultradent.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7672,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"business_update","footnotes":""},"sector":[],"importance":[],"class_list":["post-80686","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n